Medcaptain Medical Technology
China - ShenzhenBiotechnology
Focus: Medcaptain is a publicly listed Chinese biotechnology company founded in 2011, specializing in infusion devices and respiratory therapeutics. The company operates as a mid-cap biotech with a focused product portfolio in acute care and emergency medicine.
Profile data last refreshed 23h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Medcaptain Medical Technology
AI assessmentNot HiringNo open roles listed right now. Follow Medcaptain Medical Technology to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Medcaptain Medical Technology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
LOE Approaching
Auto-injector antidote for acute nerve agent exposure; lifecycle pressure represents significant revenue cliff.
Help build intelligence for Medcaptain Medical Technology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.